Back
Glacier Bancorp, Inc. Vs. Apellis Pharmaceuticals, Inc. Industry Stock Comparison
Buy
55
GBCI
Glacier Bancorp, Inc.
Last Price:
$44.05
Seasonality Move:
7.06%
Buy
53
APLS
Apellis Pharmaceuticals, Inc.
Last Price:
$25.12
Seasonality Move:
5.58%
Buy
55
Glacier Bancorp, Inc. (GBCI)
is a Buy
Is Glacier Bancorp, Inc. a Buy, Sell or Hold?
-
The current Glacier Bancorp, Inc. [GBCI] share price is $44.05. The Score for GBCI is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
GBCI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Apellis Pharmaceuticals, Inc. (APLS)
is a Buy
Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals, Inc. [APLS] share price is $25.12. The Score for APLS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GBCI Stock Price Chart
What is Glacier Bancorp, Inc.'s stock price today?
-
The Glacier Bancorp, Inc. share price today is $44.05Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GBCI is experiencing selling pressure, which indicates risk of future bearish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals, Inc.'s stock price today?
-
The Apellis Pharmaceuticals, Inc. share price today is $25.12Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight selling pressure.
GBCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.53 | Buy |
| Relative Strength Index (14 RSI): | 48.94 | Sell |
| Chaikin Money Flow: | -489216 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.8 - 45.24) | Buy |
| Bollinger Bands (100): | (42.47 - 48.31) | Sell |
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.77 | Buy |
| Relative Strength Index (14 RSI): | 59.84 | Buy |
| Chaikin Money Flow: | -339202 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.17 - 25.45) | Buy |
| Bollinger Bands (100): | (21.39 - 27.15) | Buy |
GBCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.23 | Sell |
| 20-day SMA: | 44.33 | Sell |
| 50-day SMA: | 42.95 | Buy |
| 200-day SMA: | 44.12 | Sell |
| 8-day EMA: | 44.82 | Sell |
| 20-day EMA: | 44.39 | Sell |
| 50-day EMA: | 44.1 | Sell |
| 200-day EMA: | 44.79 | Sell |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.07 | Buy |
| 20-day SMA: | 24.48 | Buy |
| 50-day SMA: | 23.16 | Buy |
| 200-day SMA: | 21.91 | Buy |
| 8-day EMA: | 25.03 | Buy |
| 20-day EMA: | 24.33 | Buy |
| 50-day EMA: | 23.6 | Buy |
| 200-day EMA: | 24.33 | Buy |
Glacier Bancorp, Inc. Earnings Growth & GBCI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $0.48 per share.
Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.44 per share, and an increase next year of $0.91 per share.
Glacier Bancorp, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apellis Pharmaceuticals, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||